AVIDA The Vidaza® (Azacitidine) Patient Registry

Completed

Conditions studied: Myelodysplastic Syndromes

In brief

This registry is a prospective, multi-center, observational study compiling data on the natural history and management of patients receiving Vidaza, and will provide unique insights into the management of myelodysplastic syndromes (MDS) and other hematological disorders and the impact of these disorders on patients.

Key facts

Study ID

NCT00481273

Run by

Celgene

People needed

479

Starts

2006-10-31

Expected to finish

2010-08-31

Last updated by the study team

2018-05-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient who is deemed appropriate for treatment with Vidaza® by his or her clinician, but who has not already started receiving Vidaza® treatment.
• Patient who is able to read and speak English.
• Patient who is willing and able to provide informed consent.
• Patient who agrees to complete patient assessment questionnaires.

You may not qualify if…

• Patients who are currently being treated with Vidaza®.
• Patients who are concurrently participating in a clinical trial.
• Patients unwilling or unable to complete the baseline and follow-up questionnaires.
• Patients who are deemed inappropriate for treatment with Vidaza®.

Where it is running

• AVIDA Registry Help — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.